Logo of nihpaLink to Publisher's site
PMC full text:
Gastroenterology. Author manuscript; available in PMC 2014 Jun 1.
Published in final edited form as:
Gastroenterology. 2013 Jun; 144(7): 1530–1542.e12.
Published online 2013 Feb 16. doi: 10.1053/j.gastro.2013.02.009

Figure 3

An external file that holds a picture, illustration, etc.
Object name is nihms448581f3.jpg
Jag-1 mediates tumor-supporting propertied of YAP in HCC cells

(A) Jag-1 and YAP expression and cell proliferation of PLC/PRF/5 cells after overexpression of Jag-1 and concomitant inhibition of YAP by gene-specific siRNA. Statistics compares Jag-1/scramble siRNA with Jag-1/YAP siRNA. (B) Jag-1, YAP, Hes-1 protein levels and proliferation of PLC/PRF/5 cells after overexpression YAPS127A and simultaneous Jag-1 silencing. Statistical testing compares Jag-1 siRNA and YAPS127A/Jag-1 siRNA. (C) Hes-1 expression and cell proliferation of PLC/PRF/5 cells after expression of YAP and concomitant administration of the Notch transcriptional complex inhibitor SAHM1. Statistics compared SAHM1 with YAP/SAHM1. For (A) and (B) untreated (control) and scramble siRNA-transfected cells served as controls. For (C) untreated and DMSO-treated cells were used as controls. For (A), (B), and (C), cell proliferation was measured 24, 48, and 72 h after transfection. Actin was used as loading control. Values represent means ± SD. Statistical test: Mann-Whitney U. n.s. - not significant, **p<0.01, ***p<0.001.

Images in this article

  • Figure 1
  • Figure 2
  • Figure 3
  • Figure 4
  • Figure 5
  • Figure 6
  • Figure 7

Click on the image to see a larger version.

-